Janus Henderson Group’s Tango Therapeutics TNGX Stock Holding History
Bought
Maintained
Sold
Other funds holding TNGX
RI
BCM
TCM
FCM
WP
NI
TGI
Janus Henderson Group's TNGX Position: Q1 2026 in Review
Janus Henderson Group reduced its Tango Therapeutics (TNGX) stake by 9.4% in Q1 2026, selling an estimated $3.47M and leaving 2,394,972 shares worth $50.1M. The position accounts for 0.02% of the portfolio, ranked #412.
Janus Henderson Group first reported a position in TNGX in Q3 2020 and has held it in 17 quarters since. 194 funds tracked by Wall St. Rank hold TNGX as of Q1 2026.
- Janus Henderson Group held 2,394,972 shares of Tango Therapeutics worth $50.1M as of Q1 2026.
- Janus Henderson Group sold 249,265 Tango Therapeutics shares in Q1 2026, an estimated $3.47M.
- Tango Therapeutics made up 0.02% of Janus Henderson Group's portfolio in Q1 2026, its #412 holding.
- Janus Henderson Group first reported a position in Tango Therapeutics in Q3 2020 and has held it in 17 quarters since.
- 194 funds tracked by Wall St. Rank held Tango Therapeutics as of Q1 2026.
Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.